Highlights FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq Other stock markets 01:30:00 04/06/2024 am IST			5-day change	1st Jan Change
21.55 ^USD	+0.14%		0.00%	+124.25%

04/06	Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete	MT
04/06	Fusion Pharmaceuticals Inc.(NasdaqGS:FUSN) dropped from NASDAQ Biotechnology Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete	05/06	MT
AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders.	04/06	CI
Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal	01/06	MT
Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal	30/05	MT
Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer	10/05	CI
Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Fusion Pharmaceuticals Inc. Presents Interim Efficacy and Safety Data from the Phase 2 TATCIST Open-Label Clinical Trial Evaluating FPI-2265	10/04	CI
Fusion Pharmaceuticals Narrows Q4 Loss; Enters Sale Deal With AstraZeneca	21/03	MT
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03	CI
Fusion Pharmaceuticals Downgraded by RBC to Sector Perform From Outperform, Speculative Risk Removed, Price Target Raised to $21 From $16	20/03	MT
Sector Update: Health Care Stocks Rise Late Afternoon	20/03	MT
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	20/03	MT
Sector Update: Health Care	20/03	MT
Top Midday Gainers	19/03	MT
Top Stories at Midday: February US Housing Starts Rise; AstraZeneca to Acquire Fusion Pharmaceuticals; IFF to Sell Pharma Solutions Unit; Unilever to Spin Off Ice Cream Unit; MicroStrategy Completes Notes Offering; Super Micro Computer Files Shelf; Nvidia Unveils Latest GPU	19/03	MT
Fed Policy Meeting in Focus as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Tuesday	19/03	MT
AstraZeneca Strikes $2.4 Billion Deal to Buy Fusion Pharmaceuticals	19/03	MT
AstraZeneca to Acquire Fusion Pharmaceuticals for $2.4 Billion; Fusion Shares Rise Pre-Bell	19/03	MT
Fusion Pharmaceuticals Inc. agreed to acquire Exclusive Worldwide License for Actinium-Based PSMA Targeted Radiotherapy from Heidelberg University and Euratom represented by the European Commission, Joint Research Centre.	16/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights FUSN PHAR

Equities

FUSN

CA36118A1003

Highlights

Filters